| Original language | English |
|---|---|
| Pages (from-to) | 1735-1738 |
| Number of pages | 4 |
| Journal | Genes and Diseases |
| Volume | 10 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Sept 2023 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Genes and Diseases, Vol. 10, No. 5, 09.2023, p. 1735-1738.
Research output: Contribution to journal › Journal article › peer-review
TY - JOUR
T1 - Development of an orally bioavailable selective inhibitor of the menin-MLL
AU - Zhong, Hai Jing
AU - Wang, Wanhe
AU - Zhou, Wei
AU - Liang, Jia Xin
AU - Cheng, Yung Chi
AU - Ma, Dik Lung
AU - Leung, Chung Hang
N1 - This work is supported by the Science and Technology Development Fund (Macau SAR, China) (No. 0007/2020/A1, 0020/2022/A1), the State Key Laboratory of Quality Research in Chinese Medicine (University of Macau) (SKL-QRCM(UM)-2020-2022), the University of Macau (China) (MYRG2019-00002-ICMS, MYRG2020-00017-ICMS), 2022 Internal Research Grant of SKL-QRCM (University of Macau) (QRCM-IRG2022-011), the National Natural Science Foundation of China, China (No. 22077109, 21775131), the HKBU SKLEBA Research Grant (SKLP_2223_P03), the National Natural Science Foundation of China (No. 82204482), the Guangdong Basic and Applied Basic Research Foundation (China) (No. 2021A1515012520), Young Elite Scientists Sponsorship Program by CACM (China) (No. 2021-QNRC2-B22), Guangzhou Basic and Applied Basic Research Foundation (China) (No. 202102020203), and the Fundamental Research Funds for the Central Universities (China) (No. 11620355). A part of the research is supported by a trust fund for Yung-Chi Cheng's lab at Yale University. © 2022 The Authors.
PY - 2023/9
Y1 - 2023/9
UR - http://www.scopus.com/inward/record.url?scp=85141754240&partnerID=8YFLogxK
U2 - 10.1016/j.gendis.2022.10.005
DO - 10.1016/j.gendis.2022.10.005
M3 - Journal article
AN - SCOPUS:85141754240
SN - 2352-4820
VL - 10
SP - 1735
EP - 1738
JO - Genes and Diseases
JF - Genes and Diseases
IS - 5
ER -